| Literature DB >> 27239029 |
Curtis A Nutter1, Elizabeth A Jaworski1, Sunil K Verma1, Vaibhav Deshmukh2, Qiongling Wang3, Olga B Botvinnik4, Mario J Lozano5, Ismail J Abass6, Talha Ijaz1, Allan R Brasier7, Nisha J Garg8, Xander H T Wehrens9, Gene W Yeo10, Muge N Kuyumcu-Martinez11.
Abstract
Alternative splicing (AS) defects that adversely affect gene expression and function have been identified in diabetic hearts; however, the mechanisms responsible are largely unknown. Here, we show that the RNA-binding protein RBFOX2 contributes to transcriptome changes under diabetic conditions. RBFOX2 controls AS of genes with important roles in heart function relevant to diabetic cardiomyopathy. RBFOX2 protein levels are elevated in diabetic hearts despite low RBFOX2 AS activity. A dominant-negative (DN) isoform of RBFOX2 that blocks RBFOX2-mediated AS is generated in diabetic hearts. DN RBFOX2 interacts with wild-type (WT) RBFOX2, and ectopic expression of DN RBFOX2 inhibits AS of RBFOX2 targets. Notably, DN RBFOX2 expression is specific to diabetes and occurs at early stages before cardiomyopathy symptoms appear. Importantly, DN RBFOX2 expression impairs intracellular calcium release in cardiomyocytes. Our results demonstrate that RBFOX2 dysregulation by DN RBFOX2 is an early pathogenic event in diabetic hearts.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27239029 PMCID： PMC4899142 DOI： 10.1016/j.celrep.2016.05.002
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423